Contact – +1-276-477-5910
 Email – info@supplydemandmarketresearch.com

Home >>

Food & Beverages

>>

EMEA Europe Middle East and Africa Influenza Vaccine Market


EMEA (Europe, Middle East and Africa) Influenza Vaccine Market Report 2018

Report code: SDMRFO4867 | Industry: Food & Beverages | Published On: 3/2/2018


In this report, the EMEA Influenza Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Influenza Vaccine for these regions, from 2013 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Influenza Vaccine market competition by top manufacturers/players, with Influenza Vaccine sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Children
Adults
Elderly
Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

Table  of  Contents

EMEA  (Europe,  Middle  East  and  Africa)  Influenza  Vaccine  Market  Report  2018
1  Influenza  Vaccine  Overview
        1.1  Product  Overview  and  Scope  of  Influenza  Vaccine
        1.2  Classification  of  Influenza  Vaccine
                1.2.1  EMEA  Influenza  Vaccine  Market  Size  (Sales)  Comparison  by  Type  (2013-2025)
                1.2.2  EMEA  Influenza  Vaccine  Market  Size  (Sales)  Market  Share  by  Type  (Product  Category)  in  2017
                1.2.3  Trivalent  Influenza  Vaccine
                1.2.4  Quadrivalent  Influenza  Vaccine
                1.2.5  Other
        1.3  EMEA  Influenza  Vaccine  Market  by  Application/End  Users
                1.3.1  EMEA  Influenza  Vaccine  Sales  (Volume)  and  Market  Share  Comparison  by  Application  (2013-2025)
                1.3.2  Children
                1.3.3  Adults
                1.3.4  Elderly
                1.3.5  Pregnancy
        1.4  EMEA  Influenza  Vaccine  Market  by  Region
                1.4.1  EMEA  Influenza  Vaccine  Market  Size  (Value)  Comparison  by  Region  (2013-2025)
                1.4.2  Europe  Status  and  Prospect  (2013-2025)
                1.4.3  Middle  East  Status  and  Prospect  (2013-2025)
                1.4.4  Africa  Status  and  Prospect  (2013-2025)
        1.5  EMEA  Market  Size  (Value  and  Volume)  of  Influenza  Vaccine  (2013-2025)
                1.5.1  EMEA  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2025)
                1.5.2  EMEA  Influenza  Vaccine  Revenue  and  Growth  Rate  (2013-2025)

2  EMEA  Influenza  Vaccine  Competition  by  Manufacturers/Players/Suppliers,  Region,  Type  and  Application
        2.1  EMEA  Influenza  Vaccine  Market  Competition  by  Players/Manufacturers
                2.1.1  EMEA  Influenza  Vaccine  Sales  Volume  and  Market  Share  of  Major  Players  (2013-2018)
                2.1.2  EMEA  Influenza  Vaccine  Revenue  and  Share  by  Players  (2013-2018)
                2.1.3  EMEA  Influenza  Vaccine  Sale  Price  by  Players  (2013-2018)
        2.2  EMEA  Influenza  Vaccine  (Volume  and  Value)  by  Type/Product  Category
                2.2.1  EMEA  Influenza  Vaccine  Sales  and  Market  Share  by  Type  (2013-2018)
                2.2.2  EMEA  Influenza  Vaccine  Revenue  and  Market  Share  by  Type  (2013-2018)
                2.2.3  EMEA  Influenza  Vaccine  Sale  Price  by  Type  (2013-2018)
        2.3  EMEA  Influenza  Vaccine  (Volume)  by  Application
        2.4  EMEA  Influenza  Vaccine  (Volume  and  Value)  by  Region
                2.4.1  EMEA  Influenza  Vaccine  Sales  and  Market  Share  by  Region  (2013-2018)
                2.4.2  EMEA  Influenza  Vaccine  Revenue  and  Market  Share  by  Region  (2013-2018)
                2.4.3  EMEA  Influenza  Vaccine  Sales  Price  by  Region  (2013-2018)

3  Europe  Influenza  Vaccine  (Volume,  Value  and  Sales  Price),  by  Players,  Countries,  Type  and  Application
        3.1  Europe  Influenza  Vaccine  Sales  and  Value  (2013-2018)
                3.1.1  Europe  Influenza  Vaccine  Sales  Volume  and  Growth  Rate  (2013-2018)
                3.1.2  Europe  Influenza  Vaccine  Revenue  and  Growth  Rate  (2013-2018)
        3.2  Europe  Influenza  Vaccine  Sales  and  Market  Share  by  Type
        3.3  Europe  Influenza  Vaccine  Sales  and  Market  Share  by  Application
        3.4  Europe  Influenza  Vaccine  Sales  Volume  and  Value  (Revenue)  by  Countries
                3.4.1  Europe  Influenza  Vaccine  Sales  Volume  by  Countries  (2013-2018)
                3.4.2  Europe  Influenza  Vaccine  Revenue  by  Countries  (2013-2018)
                3.4.3  Germany  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                3.4.4  France  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                3.4.5  UK  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                3.4.6  Russia  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                3.4.7  Italy  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                3.4.8  Benelux  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)

4  Middle  East  Influenza  Vaccine  (Volume,  Value  and  Sales  Price),  by  Region,  Type  and  Application
        4.1  Middle  East  Influenza  Vaccine  Sales  and  Value  (2013-2018)
                4.1.1  Middle  East  Influenza  Vaccine  Sales  Volume  and  Growth  Rate  (2013-2018)
                4.1.2  Middle  East  Influenza  Vaccine  Revenue  and  Growth  Rate  (2013-2018)
        4.2  Middle  East  Influenza  Vaccine  Sales  and  Market  Share  by  Type
        4.3  Middle  East  Influenza  Vaccine  Sales  and  Market  Share  by  Application
        4.4  Middle  East  Influenza  Vaccine  Sales  Volume  and  Value  (Revenue)  by  Countries
                4.4.1  Middle  East  Influenza  Vaccine  Sales  Volume  by  Countries  (2013-2018)
                4.4.2  Middle  East  Influenza  Vaccine  Revenue  by  Countries  (2013-2018)
                4.4.3  Saudi  Arabia  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                4.4.4  Israel  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                4.4.5  UAE  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                4.4.6  Iran  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)

5  Africa  Influenza  Vaccine  (Volume,  Value  and  Sales  Price)  by  Players,  Countries,  Type  and  Application
        5.1  Africa  Influenza  Vaccine  Sales  and  Value  (2013-2018)
                5.1.1  Africa  Influenza  Vaccine  Sales  Volume  and  Growth  Rate  (2013-2018)
                5.1.2  Africa  Influenza  Vaccine  Revenue  and  Growth  Rate  (2013-2018)
        5.2  Africa  Influenza  Vaccine  Sales  and  Market  Share  by  Type
        5.3  Africa  Influenza  Vaccine  Sales  and  Market  Share  by  Application
        5.4  Africa  Influenza  Vaccine  Sales  Volume  and  Value  (Revenue)  by  Countries
                5.4.1  Africa  Influenza  Vaccine  Sales  Volume  by  Countries  (2013-2018)
                5.4.2  Africa  Influenza  Vaccine  Revenue  by  Countries  (2013-2018)
                5.4.3  South  Africa  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                5.4.4  Nigeria  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                5.4.5  Egypt  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)
                5.4.6  Algeria  Influenza  Vaccine  Sales  and  Growth  Rate  (2013-2018)

6  EMEA  Influenza  Vaccine  Manufacturers/Players  Profiles  and  Sales  Data
        6.1  GSK
                6.1.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.1.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.1.2.1  Product  A
                        6.1.2.2  Product  B
                6.1.3  GSK  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.1.4  Main  Business/Business  Overview
        6.2  Sinovac
                6.2.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.2.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.2.2.1  Product  A
                        6.2.2.2  Product  B
                6.2.3  Sinovac  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.2.4  Main  Business/Business  Overview
        6.3  Changsheng
                6.3.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.3.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.3.2.1  Product  A
                        6.3.2.2  Product  B
                6.3.3  Changsheng  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.3.4  Main  Business/Business  Overview
        6.4  CCBIO
                6.4.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.4.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.4.2.1  Product  A
                        6.4.2.2  Product  B
                6.4.3  CCBIO  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.4.4  Main  Business/Business  Overview
        6.5  Aleph  Biomedical
                6.5.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.5.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.5.2.1  Product  A
                        6.5.2.2  Product  B
                6.5.3  Aleph  Biomedical  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.5.4  Main  Business/Business  Overview
        6.6  Sanofi
                6.6.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.6.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.6.2.1  Product  A
                        6.6.2.2  Product  B
                6.6.3  Sanofi  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.6.4  Main  Business/Business  Overview
        6.7  Lanzhou  Institute  Of  Biological  Product
                6.7.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.7.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.7.2.1  Product  A
                        6.7.2.2  Product  B
                6.7.3  Lanzhou  Institute  Of  Biological  Product  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.7.4  Main  Business/Business  Overview
        6.8  Siobp
                6.8.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.8.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.8.2.1  Product  A
                        6.8.2.2  Product  B
                6.8.3  Siobp  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.8.4  Main  Business/Business  Overview
        6.9  Hualan  Bio
                6.9.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.9.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.9.2.1  Product  A
                        6.9.2.2  Product  B
                6.9.3  Hualan  Bio  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.9.4  Main  Business/Business  Overview
        6.10  Tianyuan  Bio-Pharma
                6.10.1  Company  Basic  Information,  Manufacturing  Base  and  Competitors
                6.10.2  Influenza  Vaccine  Product  Type,  Application  and  Specification
                        6.10.2.1  Product  A
                        6.10.2.2  Product  B
                6.10.3  Tianyuan  Bio-Pharma  Influenza  Vaccine  Sales,  Revenue,  Price  and  Gross  Margin  (2013-2018)
                6.10.4  Main  Business/Business  Overview
        6.11  Vaxtec
        6.12  Hissen
        6.13  Abbott
        6.14  Novartis
        6.15  Tasly&Jenner
        6.16  Tiantan

7  Influenza  Vaccine  Manufacturing  Cost  Analysis
        7.1  Influenza  Vaccine  Key  Raw  Materials  Analysis
                7.1.1  Key  Raw  Materials
                7.1.2  Price  Trend  of  Key  Raw  Materials
                7.1.3  Key  Suppliers  of  Raw  Materials
                7.1.4  Market  Concentration  Rate  of  Raw  Materials
        7.2  Proportion  of  Manufacturing  Cost  Structure
                7.2.1  Raw  Materials
                7.2.2  Labor  Cost
                7.2.3  Manufacturing  Expenses
        7.3  Manufacturing  Process  Analysis  of  Influenza  Vaccine

8  Industrial  Chain,  Sourcing  Strategy  and  Downstream  Buyers
        8.1  Influenza  Vaccine  Industrial  Chain  Analysis
        8.2  Upstream  Raw  Materials  Sourcing
        8.3  Raw  Materials  Sources  of  Influenza  Vaccine  Major  Manufacturers  in  2017
        8.4  Downstream  Buyers

9  Marketing  Strategy  Analysis,  Distributors/Traders
        9.1  Marketing  Channel
                9.1.1  Direct  Marketing
                9.1.2  Indirect  Marketing
                9.1.3  Marketing  Channel  Development  Trend
        9.2  Market  Positioning
                9.2.1  Pricing  Strategy
                9.2.2  Brand  Strategy
                9.2.3  Target  Client
        9.3  Distributors/Traders  List

10  Market  Effect  Factors  Analysis
        10.1  Technology  Progress/Risk
                10.1.1  Substitutes  Threat
                10.1.2  Technology  Progress  in  Related  Industry
        10.2  Consumer  Needs/Customer  Preference  Change
        10.3  Economic/Political  Environmental  Change

11  EMEA  Influenza  Vaccine  Market  Forecast  (2018-2025)
        11.1  EMEA  Influenza  Vaccine  Sales,  Revenue  and  Price  Forecast  (2018-2025)
                11.1.1  EMEA  Influenza  Vaccine  Sales  and  Growth  Rate  Forecast  (2018-2025)
                11.1.2  EMEA  Influenza  Vaccine  Revenue  and  Growth  Rate  Forecast  (2018-2025)
                11.1.3  EMEA  Influenza  Vaccine  Price  and  Trend  Forecast  (2018-2025)
        11.2  EMEA  Influenza  Vaccine  Sales,  Revenue  and  Growth  Rate  Forecast  by  Region  (2018-2025)
        11.3  Europe  Influenza  Vaccine  Sales,  Revenue  and  Growth  Rate  Forecast  by  Region  (2018-2025)
        11.4  Middle  Eastt  Influenza  Vaccine  Sales,  Revenue  and  Growth  Rate  Forecast  by  Region  (2018-2025)
        11.5  Africa  Influenza  Vaccine  Sales,  Revenue  and  Growth  Rate  Forecast  by  Region  (2018-2025)
        11.6  EMEA  Influenza  Vaccine  Sales  Forecast  by  Type  (2018-2025)
        11.7  EMEA  Influenza  Vaccine  Sales  Forecast  by  Application  (2018-2025)

12  Research  Findings  and  Conclusion

13  Appendix
        13.1  Methodology/Research  Approach
                13.1.1  Research  Programs/Design
                13.1.2  Market  Size  Estimation
                13.1.3  Market  Breakdown  and  Data  Triangulation
        13.2  Data  Source
                13.2.1  Secondary  Sources
                13.2.2  Primary  Sources
        13.3  Disclaimer


List of Tables and Figures

Figure Product Picture of Influenza Vaccine
Figure EMEA Influenza Vaccine Sales Volume (K Doses) by Type (2013-2025)
Figure EMEA Influenza Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Trivalent Influenza Vaccine Product Picture
Figure Quadrivalent Influenza Vaccine Product Picture
Figure Other Product Picture
Figure EMEA Influenza Vaccine Sales Volume (K Doses) by Application (2013-2025)
Figure EMEA Sales Market Share of Influenza Vaccine by Application in 2017
Figure Children Examples
Table Key Downstream Customer in Children
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Elderly Examples
Table Key Downstream Customer in Elderly
Figure Pregnancy Examples
Table Key Downstream Customer in Pregnancy
Figure EMEA Influenza Vaccine Market Size (Million USD) by Region (2013-2025)
Figure Europe Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Influenza Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Influenza Vaccine Sales Volume and Growth Rate (2013-2025)
Figure EMEA Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Influenza Vaccine Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table EMEA Influenza Vaccine Sales Volume (K Doses) of Major Players (2013-2018)
Table EMEA Influenza Vaccine Sales Share by Players (2013-2018)
Figure 2017 Influenza Vaccine Sales Share by Players
Figure 2017 Influenza Vaccine Sales Share by Players
Figure EMEA Influenza Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Influenza Vaccine Revenue (Million USD) by Players (2013-2018)
Table EMEA Influenza Vaccine Revenue Share by Players (2013-2018)
Table 2017 EMEA Influenza Vaccine Revenue Share by Players
Table 2017 EMEA Influenza Vaccine Revenue Share by Players
Table EMEA Influenza Vaccine Sale Price (USD/Dose) by Players (2013-2018)
Table EMEA Influenza Vaccine Sales (K Doses) and Market Share by Type (2013-2018)
Table EMEA Influenza Vaccine Sales Share by Type (2013-2018)
Figure Sales Market Share of Influenza Vaccine by Type (2013-2018)
Figure EMEA Influenza Vaccine Sales Market Share by Type (2013-2018)
Table EMEA Influenza Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Influenza Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Influenza Vaccine by Type in 2017
Table EMEA Influenza Vaccine Sale Price (USD/Dose) by Type (2013-2018)
Table EMEA Influenza Vaccine Sales (K Doses) and Market Share by Application (2013-2018)
Table EMEA Influenza Vaccine Sales Share by Application (2013-2018)
Figure Sales Market Share of Influenza Vaccine by Application (2013-2018)
Figure EMEA Influenza Vaccine Sales Market Share by Application in 2017
Table EMEA Influenza Vaccine Sales (K Doses) and Market Share by Region (2013-2018)
Table EMEA Influenza Vaccine Sales Share by Region (2013-2018)
Figure Sales Market Share of Influenza Vaccine by Region (2013-2018)
Figure EMEA Influenza Vaccine Sales Market Share in 2017
Table EMEA Influenza Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Influenza Vaccine Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Influenza Vaccine by Region (2013-2018)
Figure EMEA Influenza Vaccine Revenue Market Share Regions in 2017
Table EMEA Influenza Vaccine Sales Price (USD/Dose) by Region (2013-2018)
Figure Europe Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Europe Influenza Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Influenza Vaccine Sales (K Doses) by Type (2013-2018)
Table Europe Influenza Vaccine Market Share by Type (2013-2018)
Figure Europe Influenza Vaccine Market Share by Type in 2017
Table Europe Influenza Vaccine Sales (K Doses) by Application (2013-2018)
Table Europe Influenza Vaccine Market Share by Application (2013-2018)
Figure Europe Influenza Vaccine Market Share by Application in 2017
Table Europe Influenza Vaccine Sales (K Doses) by Countries (2013-2018)
Table Europe Influenza Vaccine Sales Market Share by Countries (2013-2018)
Figure Europe Influenza Vaccine Sales Market Share by Countries (2013-2018)
Figure Europe Influenza Vaccine Sales Market Share by Countries in 2017
Table Europe Influenza Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Europe Influenza Vaccine Revenue Market Share by Countries (2013-2018)
Figure Europe Influenza Vaccine Revenue Market Share by Countries (2013-2018)
Figure Europe Influenza Vaccine Revenue Market Share by Countries in 2017
Figure Germany Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure France Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure UK Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Russia Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Italy Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Benelux Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Middle East Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Middle East Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Influenza Vaccine Sales (K Doses) by Type (2013-2018)
Table Middle East Influenza Vaccine Market Share by Type (2013-2018)
Figure Middle East Influenza Vaccine Market Share by Type (2013-2018)
Table Middle East Influenza Vaccine Sales (K Doses) by Applications (2013-2018)
Table Middle East Influenza Vaccine Market Share by Applications (2013-2018)
Figure Middle East Influenza Vaccine Sales Market Share by Application in 2017
Table Middle East Influenza Vaccine Sales Volume (K Doses) by Countries (2013-2018)
Table Middle East Influenza Vaccine Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Influenza Vaccine Sales Volume Market Share by Countries in 2017
Table Middle East Influenza Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Middle East Influenza Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East Influenza Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East Influenza Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Israel Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure UAE Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Iran Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Africa Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Africa Influenza Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Influenza Vaccine Sales (K Doses) by Type (2013-2018)
Table Africa Influenza Vaccine Sales Market Share by Type (2013-2018)
Figure Africa Influenza Vaccine Sales Market Share by Type (2013-2018)
Figure Africa Influenza Vaccine Sales Market Share by Type in 2017
Table Africa Influenza Vaccine Sales (K Doses) by Application (2013-2018)
Table Africa Influenza Vaccine Sales Market Share by Application (2013-2018)
Figure Africa Influenza Vaccine Sales Market Share by Application (2013-2018)
Table Africa Influenza Vaccine Sales Volume (K Doses) by Countries (2013-2018)
Table Africa Influenza Vaccine Sales Market Share by Countries (2013-2018)
Figure Africa Influenza Vaccine Sales Market Share by Countries (2013-2018)
Figure Africa Influenza Vaccine Sales Market Share by Countries in 2017
Table Africa Influenza Vaccine Revenue (Million USD) by Countries (2013-2018)
Table Africa Influenza Vaccine Revenue Market Share by Countries (2013-2018)
Figure Africa Influenza Vaccine Revenue Market Share by Countries (2013-2018)
Figure Africa Influenza Vaccine Revenue Market Share by Countries in 2017
Figure South Africa Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Nigeria Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Egypt Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Algeria Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Table GSK Influenza Vaccine Basic Information List
Table GSK Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GSK Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure GSK Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure GSK Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table Sinovac Influenza Vaccine Basic Information List
Table Sinovac Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sinovac Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Sinovac Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure Sinovac Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table Changsheng Influenza Vaccine Basic Information List
Table Changsheng Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Changsheng Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Changsheng Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure Changsheng Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table CCBIO Influenza Vaccine Basic Information List
Table CCBIO Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure CCBIO Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure CCBIO Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure CCBIO Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table Aleph Biomedical Influenza Vaccine Basic Information List
Table Aleph Biomedical Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Aleph Biomedical Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Aleph Biomedical Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure Aleph Biomedical Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table Sanofi Influenza Vaccine Basic Information List
Table Sanofi Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Sanofi Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure Sanofi Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table Lanzhou Institute Of Biological Product Influenza Vaccine Basic Information List
Table Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure Lanzhou Institute Of Biological Product Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table Siobp Influenza Vaccine Basic Information List
Table Siobp Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Siobp Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Siobp Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure Siobp Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table Hualan Bio Influenza Vaccine Basic Information List
Table Hualan Bio Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Hualan Bio Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Hualan Bio Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure Hualan Bio Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table Tianyuan Bio-Pharma Influenza Vaccine Basic Information List
Table Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Tianyuan Bio-Pharma Influenza Vaccine Sales Market Share in EMEA (2013-2018)
Figure Tianyuan Bio-Pharma Influenza Vaccine Revenue Market Share in EMEA (2013-2018)
Table Vaxtec Influenza Vaccine Basic Information List
Table Hissen Influenza Vaccine Basic Information List
Table Abbott Influenza Vaccine Basic Information List
Table Novartis Influenza Vaccine Basic Information List
Table Tasly&Jenner Influenza Vaccine Basic Information List
Table Tiantan Influenza Vaccine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Vaccine
Figure Manufacturing Process Analysis of Influenza Vaccine
Figure Influenza Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Influenza Vaccine Major Manufacturers in 2017
Table Major Buyers of Influenza Vaccine
Table Distributors/Traders List
Figure EMEA Influenza Vaccine Sales (K Doses) and Growth Rate Forecast (2018-2025)
Figure EMEA Influenza Vaccine Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Influenza Vaccine Price (USD/Dose) and Trend Forecast (2018-2025)
Table EMEA Influenza Vaccine Sales (K Doses) Forecast by Region (2018-2025)
Figure EMEA Influenza Vaccine Sales Market Share Forecast by Region (2018-2025)
Table EMEA Influenza Vaccine Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Influenza Vaccine Revenue Market Share Forecast by Region (2018-2025)
Table Europe Influenza Vaccine Sales (K Doses) Forecast by Countries (2018-2025)
Figure Europe Influenza Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Europe Influenza Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Influenza Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Influenza Vaccine Sales (K Doses) Forecast by Countries (2018-2025)
Figure Middle East Influenza Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Influenza Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Influenza Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Influenza Vaccine Sales (K Doses) Forecast by Countries (2018-2025)
Figure Africa Influenza Vaccine Sales Market Share Forecast by Countries (2018-2025)
Table Africa Influenza Vaccine Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Influenza Vaccine Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Influenza Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure EMEA Influenza Vaccine Sales Market Share Forecast by Type (2018-2025)
Table EMEA Influenza Vaccine Sales (K Doses) Forecast by Application (2018-2025)
Figure EMEA Influenza Vaccine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT